Piramal Pharma Solutions Press Releases

Press Releases

Coldstream Laboratories Awarded 5-Year Contract With the National Cancer Institute

Posted on Mon, Sep 30, 2013 @ 03:15 PM by Kathy Sue Bennett in parenteral manufacturing, in parenteral development, in sterile manufacturing, in aseptic filling

LEXINGTON, KY--(Marketwired - Sep 24, 2013) - Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that they have been awarded a 5-year contract with the National Cancer Institute ("NCI") under solicitation number N02CM37007-11 (contract# HHSN261201300031I) entitled "Development and Production of Parenteral Dosage Forms for Clinical Studies."

0 CommentsContinue Reading →

Coldstream Laboratories Expands Business Development Group

Posted on Tue, Sep 17, 2013 @ 10:42 AM by Kathy Sue Bennett in parenteral manufacturing, in sterile manufacturing

Pamela Savoy Added as Director of Business Development at Coldstream Laboratories, Inc.

0 CommentsContinue Reading →

Coldstream to Attend Generics Conference

Posted on Tue, Jul 23, 2013 @ 06:17 PM by Kathy Sue Bennett in parenteral manufacturing, in parenteral development, in sterile manufacturing, in aseptic filling

Christopher A. Verbicky, Ph.D., MBA, will be attending the “6th Product and Pipeline Enhancement for Generics Conference” in this week in Washington, D.C.  The event will take place at the Sheraton Crystal City Hotel July 23 – 25, 2013.

0 CommentsContinue Reading →

Goodwin Biotechnology and Coldstream Laboratories Announce a Collaboration to Develop and Manufacture Cytotoxic Antibody Drug Conjugates

Posted on Tue, Apr 30, 2013 @ 09:53 AM by Kathy Sue Bennett in parenteral manufacturing, in sterile manufacturing, in aseptic filling, in antibody drug conjugates

Plantation, Florida and Lexington, Kentucky-- Goodwin Biotechnology, Inc. (GBI) and Coldstream Laboratories, Inc. have established a collaboration for developing and manufacturing high-potency, highly cytotoxic materials (e.g., small molecules, protein toxins, cytotoxic antibody drug conjugates, and other bioconjugates).

0 CommentsContinue Reading →

Coldstream Partners with Local Company for Manufacture of New Equine Device

Posted on Mon, Apr 15, 2013 @ 10:46 AM by Kathy Sue Bennett in parenteral manufacturing, in sterile manufacturing, in aseptic filling

Photo Caption:  Equinext’s President and CEO, Eric Hauck, with Eric Smart, President and CEO of Coldstream Laboratories in Coldstream’s sterile manufacturing facility.

0 CommentsContinue Reading →

Coldstream Laboratories to Attend Informex 2013

Posted on Fri, Feb 08, 2013 @ 10:47 AM by Kathy Sue Bennett in lyophilization, in lyophilized products, in parenteral manufacturing, in sterile manufacturing

Representatives from Coldstream Laboratories will be attending Informex 2013 in Anaheim, CA. The event will take place at the Anaheim Convention Center February 19 - 22, 2013.

0 CommentsContinue Reading →

Eric Smart Named President and CEO of Coldstream Laboratories, Inc.

Posted on Mon, Oct 29, 2012 @ 09:09 AM by Kathy Sue Bennett in parenteral manufacturing, in eric smart, in sterile manufacturing

LEXINGTON, KY (Marketwire - October 29, 2012) – Eric W. Smart has been named the new President and CEO of Coldstream Laboratories Inc., the largest sterile pharmaceutical manufacturing facility in Kentucky.

0 CommentsContinue Reading →

Mobile Isolators in Sterile Manufacturing

Posted on Fri, Sep 07, 2012 @ 05:11 PM by Kathy Sue Bennett in parenteral manufacturing, in isolator technology, in sterile manufacturing, in aseptic filling

The sterile manufacturing facility at Coldstream Laboratories employs unique mobile isolator technology to allow flexibility in executing a wide variety of manufacturing processes. Our isolators facilitate handling of difficult-to-manufacture drug products and ensure the safety of our workforce throughout the production process.  Mobile isolators provide an ISO Class 5 environment for aseptic processing and minimize human contact with the products we manufacture.   This technology allows Coldstream to process a variety of potent drug substances such as cytotoxins in an adaptable alternative manufacturing setting when compared to standard clean rooms.

0 CommentsContinue Reading →

Benefits and Challenges of Real-Time Release of Water for Injection

Posted on Mon, Aug 13, 2012 @ 09:32 AM by Angela Harrison, Director of Technical Services in release testing, in sterile manufacturing, in water for injection

Pharmaceutical grade water is the most commonly used ingredient in sterile pharmaceutical manufacturing and acceptable water purity is critical to producing quality final drug product.  Water for Injection (WFI) is water that is purified by distillation or a purification process that is equivalent or superior to distillation in the removal of chemicals and microorganisms.  Pharmaceutical manufacturers are moving from laboratory to on-line analysis for real time water release.  Real-time release can greatly improve efficiencies and cost while allowing for increased quality assurance awareness.  Real-time release of pharmaceutical waters increases system understanding, decreases QC testing, reduces batch risk and improves process controls. 

0 CommentsContinue Reading →

Coldstream Laboratories Upgrades Sterile Manufacturing Facility

Posted on Tue, Jul 24, 2012 @ 09:42 AM by Kathy Sue Bennett in lyophilization, in lyophilized products, in sterile manufacturing, in product development

(Lexington, KY—(Marketwire—July 24, 2012) - Coldstream Laboratories, Inc., a Lexington, Kentucky, based pharmaceutical and biotechnology development and manufacturing firm announced today the initiation of significant enhancements to its manufacturing facility.  Work began last week on expanding a number of key systems in the sterile drug product manufacturing plant aimed at improving efficiencies and expanding capacity to produce parenteral products.

0 CommentsContinue Reading →